Federoff HJ - Search Results

1

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

Kooby DA, Carew JF, Halterman MW, Mack JE, Bertino JR, Blumgart LH, Federoff HJ, Fong Y. Kooby DA, et al. Among authors: federoff hj. FASEB J. 1999 Aug;13(11):1325-34. doi: 10.1096/fasebj.13.11.1325. FASEB J. 1999. PMID: 10428757

2

Utilizing tumor hypoxia to enhance oncolytic viral therapy in colorectal metastases.

Reinblatt M, Pin RH, Federoff HJ, Fong Y. Reinblatt M, et al. Among authors: federoff hj. Ann Surg. 2004 Jun;239(6):892-9; discussion 899-902. doi: 10.1097/01.sla.0000128308.36393.38. Ann Surg. 2004. PMID: 15166969 Free PMC article.

3

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer.

Bennett JJ, Kooby DA, Delman K, McAuliffe P, Halterman MW, Federoff H, Fong Y. Bennett JJ, et al. J Mol Med (Berl). 2000;78(3):166-74. doi: 10.1007/s001090000092. J Mol Med (Berl). 2000. PMID: 10868479

4

Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.

Zager JS, Delman KA, Malhotra S, Ebright MI, Bennett JJ, Kates T, Halterman M, Federoff H, Fong Y. Zager JS, et al. Mol Med. 2001 Aug;7(8):561-8. Mol Med. 2001. PMID: 11591892 Free PMC article.

5

Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector.

Carew JF, Federoff H, Halterman M, Kraus DH, Savage H, Sacks PG, Schantz SP, Shah JP, Fong Y. Carew JF, et al. Am J Surg. 1998 Nov;176(5):404-8. doi: 10.1016/s0002-9610(98)00231-1. Am J Surg. 1998. PMID: 9874422 Free article.

6

Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).

Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y. Carew JF, et al. Among authors: federoff hj. Hum Gene Ther. 1999 Jul 1;10(10):1599-606. doi: 10.1089/10430349950017608. Hum Gene Ther. 1999. PMID: 10428205

7

Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.

Cozzi PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B, Johnson P, Scardino PT, Heston WD, Fong Y. Cozzi PJ, et al. Among authors: federoff hj. FASEB J. 2001 May;15(7):1306-8. doi: 10.1096/fj.00-0533fje. FASEB J. 2001. PMID: 11344122 No abstract available.

8

A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes.

Carew JF, Kooby DA, Halterman MW, Kim SH, Federoff HJ, Fong Y. Carew JF, et al. Among authors: federoff hj. Mol Ther. 2001 Sep;4(3):250-6. doi: 10.1006/mthe.2001.0448. Mol Ther. 2001. PMID: 11545616 Free article.

9

Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer.

Bennett JJ, Delman KA, Burt BM, Mariotti A, Malhotra S, Zager J, Petrowsky H, Mastorides S, Federoff H, Fong Y. Bennett JJ, et al. Cancer Gene Ther. 2002 Nov;9(11):935-45. doi: 10.1038/sj.cgt.7700510. Cancer Gene Ther. 2002. PMID: 12386832

10

Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.

Delman KA, Zager JS, Bennett JJ, Malhotra S, Ebright MI, McAuliffe PF, Halterman MW, Federoff HJ, Fong Y. Delman KA, et al. Among authors: federoff hj. Ann Surg. 2002 Sep;236(3):337-42; discussion 342-3. doi: 10.1097/00000658-200209000-00010. Ann Surg. 2002. PMID: 12192320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters